原電池市場規模、佔有率、成長分析，按類型、原產地、應用、最終用途、地區 - 產業預測，2024-2031 年

2022年全球原電池市場規模估值為12.3億美元，從2023年的13.6億美元成長到2031年的30億美元，預計將以10.4%的複合年成長率成長。

在細胞研究需求不斷成長和慢性病患病率上升的推動下，全球原代細胞市場正在顯著成長。隨著研究人員深入研究疾病狀態的遺傳和分子基礎，對原代細胞的需求迅速增加，從而能夠開發出適合個別患者情況的標靶治療。這些個人化方法正在增強原代細胞在疾病建模和藥物篩檢中的應用，進一步加速市場擴張。癌症、心血管疾病和神經系統疾病等慢性疾病的流行增加了對這些細胞的需求，這對於研究疾病機制和測試創新療法至關重要。原代細胞具有忠實再現組織複雜生理環境的能力，對於理解疾病病理學和設計有效的干涉措施至關重要。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 案例研究

原電池市場規模：按類型和複合年成長率（2024-2031）

• 市場概況
• 造血細胞
  • 周邊血單一核細胞（PBMC）
  • 骨髓細胞
  • 臍帶血細胞
• 皮膚細胞
  • 角質形成細胞
  • 黑色素細胞
  • 纖維母細胞
• 胃腸細胞
  • 結腸上皮細胞
  • 胃上皮細胞
• 肝細胞
  • 肝細胞
  • 枯否細胞
• 肺細胞
  • 肺泡上皮細胞
  • 支氣管上皮細胞
• 腎臟細胞
  • 腎臟上皮細胞
  • 腎近曲小管細胞
• 其他細胞
  • 心肌細胞
  • 內皮細胞
  • 神經元

原電池市場規模：依來源及複合年成長率（2024-2031）

• 市場概況
• 人類起源
• 動物起源

原電池市場規模：按應用和複合年成長率（2024-2031）

• 市場概況
• 調查申請
  • 藥物發現與開發
  • 癌症研究
  • 免疫學研究
  • 幹細胞研究
• 治療應用
  • 細胞療法
  • 再生醫學

原電池市場規模：依最終用途及複合年成長率（2024-2031）

• 市場概況
• 學術/研究機構
• 製藥和生物技術公司
• 醫院和診斷實驗室
• 細胞庫和組織庫

原電池市場規模：按地區及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Thermo Fisher Scientific Inc.
• Lonza Group AG
• Merck KGaA
• PromoCell GmbH
• Cell Biologics Inc.
• ZenBio Inc.
• STEMCELL Technologies Inc.
• AllCells LLC
• American Type Culture Collection（ATCC）
• Axol Bioscience Ltd.
• Creative Bioarray
• ScienCell Research Laboratories Inc.
• BioIVT
• Corning Incorporated
• Bio-Techne Corporation
• Charles River Laboratories International Inc.
• Cureline Inc.
• Cell Applications Inc.
• iXCells Biotechnologies
• Neuromics

結論和建議

Global Primary Cells Market size was valued at USD 1.23 billion in 2022 and is poised to grow from USD 1.36 billion in 2023 to USD 3.0 billion by 2031, growing at a CAGR of 10.4% during the forecast period (2024-2031).

The global primary cells market is witnessing significant growth propelled by heightened demand for cell-based research and the growing incidence of chronic diseases. As researchers delve deeper into the genetic and molecular underpinnings of conditions, the need for primary cells has surged, allowing for the development of targeted therapies suited to individual patient profiles. This personalized approach has intensified the use of primary cells in disease modeling and drug screening, further stimulating market expansion. The prevalence of chronic diseases, including cancer, cardiovascular, and neurological disorders, has amplified the requirement for these cells, essential for studying disease mechanisms and testing innovative therapeutics. Their capacity to closely replicate the complex physiological environments of tissues makes primary cells critical for comprehending disease pathology and crafting effective interventions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Primary Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Primary Cells Market Segmental Analysis

Global Primary Cells Market is segmented by type, origin, application, end use and region. Based on type, the market is segmented into hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells and other cells. Based on origin, the market is segmented into human primary cells and animal primary cells. Based on application, the market is segmented into research applications and therapeutic applications. Based on end use, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories and cell banks and tissue banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Primary Cells Market

The Global Primary Cells market is experiencing robust growth, primarily fueled by recent advancements in Tissue Engineering and Regenerative Medicine. These innovations have elevated the importance of primary cells in creating engineered tissues and organs intended for transplantation. As the medical community increasingly prioritizes regenerative medicine for its potential to address various health issues, the demand for primary cells has surged. This heightened emphasis on tissue engineering not only enhances the capabilities of medical treatments but also significantly contributes to the overall expansion of the primary cells market, reflecting a promising outlook for future developments in healthcare.

Restraints in the Global Primary Cells Market

The global primary cells market is hindered by the inherent limitation of a short shelf life when compared to immortalized cell lines. As primary cells age, they tend to undergo senescence and may gradually lose their unique characteristics, ultimately resulting in diminished functionality. This reduced lifespan creates significant challenges for storage, transportation, and utilization in extended experimental protocols, which can adversely affect their overall market potential. Consequently, researchers and manufacturers must contend with these limitations, impacting the broader adoption and use of primary cells in various applications and hindering growth within the market.

Market Trends of the Global Primary Cells Market

The Global Primary Cells market is experiencing significant growth driven by the rising demand for personalised medicine. This innovative approach emphasizes tailoring medical treatments to individual patients by leveraging their unique genetic profiles and disease characteristics. Primary cells offer a more authentic representation of human biology, making them essential for researchers and pharmaceutical companies focused on developing targeted therapies and conducting preclinical studies. Their ability to facilitate patient-specific response evaluations enhances drug efficacy and safety assessments, thereby accelerating the adoption of primary cells in drug discovery and development. This trend positions the Global Primary Cells market as a vital component of advancing personalized healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Primary Cells Market Size by By Type & CAGR (2024-2031)

• Market Overview
• Hematopoietic Cells
  • Peripheral Blood Mononuclear Cells (Pbmcs)
  • Bone Marrow Cells
  • Cord Blood Cells
• Skin Cells
  • Keratinocytes
  • Melanocytes
  • Fibroblasts
• Gastrointestinal Cells
  • Colonic Epithelial Cells
  • Gastric Epithelial Cells
• Liver Cells
  • Hepatocytes
  • Kupffer Cells
• Lung Cells
  • Alveolar Epithelial Cells
  • Bronchial Epithelial Cells
• Renal Cells
  • Renal Epithelial Cells
  • Renal Proximal Tubule Cells
• Other Cells
  • Cardiomyocytes
  • Endothelial Cells
  • Neurons

Global Primary Cells Market Size by Origin & CAGR (2024-2031)

• Market Overview
• Human Primary Cells
• Animal Primary Cells

Global Primary Cells Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
  • Drug Discovery and Development
  • Cancer Research
  • Immunology Research
  • Stem Cell Research
• Therapeutic Applications
  • Cell Therapy
  • Regenerative Medicine

Global Primary Cells Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Cell Banks and Tissue Banks

Global Primary Cells Market Size & CAGR (2024-2031)

• North America (Type, Origin, Application, End Use)
  • USA
  • Canada
• Europe (Type, Origin, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Origin, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Origin, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Origin, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Biologics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZenBio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllCells LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection (ATCC)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axol Bioscience Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cureline Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Applications Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iXCells Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuromics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations